Harnessing the immune system's arsenal: Producing human monoclonal antibodies for therapeutics and investigating immune responses

F1000 Biology Reports

Volumn 3, Issue 1, 2011, Pages

  Sullivan, Meghan ^a   Kaur, Kaval ^a   Pauli, Noel ^a   Wilson, Patrick C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MACROGOL; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT ANTIBODY;

2009 H1N1 INFLUENZA; AFFINITY CHROMATOGRAPHY; ANTIBODY ENGINEERING; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; B LYMPHOCYTE; BACTERIOPHAGE; CELL IMMORTALIZATION; CELL SELECTION; COMPLEMENTARITY DETERMINING REGION; CROSS REACTION; CRYSTAL STRUCTURE; DRUG SAFETY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC VARIABILITY; GLYCOSYLATION; HEAVY CHAIN; HISTORY OF MEDICINE; HUMAN; HYBRIDOMA CELL CULTURE; IMMUNE RESPONSE; INFLUENZA; INNATE IMMUNITY; LIGHT CHAIN; LYMPHOCYTE TRANSFORMATION; MEMORY CELL; NONHUMAN; PHAGE DISPLAY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SERUM SICKNESS; TRANSGENIC MOUSE; VIRUS STRAIN; VIRUS TRANSFORMATION;

EID: 80052247304     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B3-17     Document Type: Review

References (31)

1. Llewelyn MB, Hawkins RE, Russell SJ: Discovery of antibodies. BMJ 1992, 305:1269-72.
2. Burnet FM: A modification of Jerne's theory of antibody production using the concept of clonal selection. Australian Journal of Science 1957, 20:67-9.
3. Talmage DW: Immunological specificity, unique combinations of selected natural globulins provide an alternative to the classical concept. Science 1959, 129:1643-8.
4. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-7.
5. Bloom AD, Nakamura FT: Establishment of a tetraploid, immunoglobulin-producing cell line from the hybridization of two human lymphocyte lines. Proc Natl Acad Sci U S A 1974, 71:2689-92.
6. Olsson L, Kaplan HS: Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A 1980, 77:5429-31.
7. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G: Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986, 321:522-5.
8. The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998, 102:531-7.
9. Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, Schramm SR, Kuo CC, Mashayekh R, Wymore K, McCabe JG, Munoz- O'Regan D, O'Donnell SL, Lapachet ES, Bengoechea T, Fishwild DM, Carmack CE, Kay RM, Huszar D: Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 1994, 368:856-9.
10. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-9.
11. Newman R, Alberts J, Anderson D, Carner K, Heard C, Norton F, Raab R, Reff M, Shuey S, Hanna N: "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology (N Y) 1992, 10:1455-60.
12. Yu X, McGraw PA, House FS, Crowe JE Jr.: An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods 2008, 336:142-51.
13. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE Jr.: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-6.
14. Steinitz M, Klein G, Koskimies S, Makel O: EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977, 269:420-2.
15. Rosén A, Gergely P, Jondal M, Klein G, Britton S: Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 1977, 267:52-4.
16. Casali P, Inghirami G, Nakamura M, Davies TF, Notkins AL: Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. Science 1986, 234:476-9.
17. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004, 10:871-5.
18. Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV, van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA, Spits H, Beaumont T:Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med 2010, 16:123-8.
19. McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990, 348:552-554.
20. McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990, 348:552-554.
21. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA: Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-51.
22. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA: Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009, 16:265-73.
23. Zhu J, Petersen S, Tessarollo L, Nussenzweig A: Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol 2001, 11:105-9.
24. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC: Predominant autoantibody production by early human B cell precursors. Science 2003, 301:1374-7.
25. Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC: Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 2009, 206:139-51.
26. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E: Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005, 201:1659-67.
27. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC: Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-71.
28. Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, Wilson PC: Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009, 4:372-84.
29. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O'Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011, 208:181-93.
30. Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P: Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 2010, 6:e1000796.
31. Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ: Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-4.